


| Press Release: Novartis expands Kymriah(R) manufacturing footprint with first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia |
|
-- Novartis global CAR-T manufacturing footprint now spans four continents, bringing Kymriah closer to patients and healthcare professionals around. the world. -- Prestigious FBRI is recognized for its world-class expertise and. established practice in CAR-T cell therapy. -- Global CAR-T manufacturing growth includes recent FDA approval for.
Posted: 2020-10-30 07:22:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.